PPBT (Purple Biotech) Buyback Yield %: -47.13 (As of Jul. 07, 2026)


PPBT Purple Biotech Ltd PPBT
19 GF Score
Price $1.70
! 2 Warning Signs
View Full Analysis

What is Purple Biotech Buyback Yield %?

Purple Biotech PPBT +1.76% 19 Buyback Yield % is -47.13 as of Jul. 07, 2026. GuruFocus rates PPBT with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 740 Biotechnology companies, Purple Biotech ranks worse than 82.57% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Purple Biotech's current buyback yield was -47.13%.

Purple Biotech Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Purple Biotech's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech Buyback Yield % Chart

Purple Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.81 -5.90 -7.95 -47.82 -51.62

Purple Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.77 -75.37 -109.56 -42.37 -47.13

PPBT vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, Purple Biotech's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Purple Biotech's Buyback Yield % falls into.


PPBT
19GF Score
Purple Biotech Ltd PPBT
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Purple Biotech Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Purple Biotech's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 3.153) / 6.108175
=-51.62%

Purple Biotech's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 2.932) / 3.76528
=-77.87%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -47.13 mean?
Purple Biotech (PPBT) has a Buyback Yield % of -47.13 as of Jul. 07, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Purple Biotech and its competitors. According to the industry distribution chart, Purple Biotech ranks #611 out of 740 companies in the Biotechnology industry, placing it in the top 82.6%.
Is Purple Biotech's Buyback Yield % too high?
Purple Biotech's current Buyback Yield % is -47.13. Based on the distribution chart, Purple Biotech ranks #611 out of 740 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Purple Biotech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Purple Biotech's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Purple Biotech ranks #611 out of 740 companies for Buyback Yield %. This places Purple Biotech in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Purple Biotech and its competitors. Purple Biotech's current Buyback Yield % is -47.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Purple Biotech stock overvalued right now?
Purple Biotech (PPBT) has a current Buyback Yield % of -47.13. The current Buyback Yield % is -47.13. Purple Biotech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Purple Biotech (PPBT), the current Buyback Yield % is -47.13 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Purple Biotech Business Description

Other Exchanges PPBT:Israel
Address 4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
19GF Score

Get the complete analysis for PPBT

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.70
Price